Key result
Percutaneous mitral valvotomy is associated with decreased platelet, thrombin, and inflammatory markers in mitral stenosis.
Why the study?
Does percutaneous mitral valvotomy reduce platelet, coagulation, fibrinolytic, and inflammatory activities in patients with mitral stenosis?
Observational (n=88)
Does percutaneous mitral valvotomy reduce platelet, coagulation, fibrinolytic, and inflammatory activities in patients with mitral stenosis?
Percutaneous mitral valvotomy significantly reduces heightened inflammatory, platelet, thrombin, and fibrinolytic activities in patients with mitral stenosis, likely due to improved hemodynamics.
Answers are grounded in this paper and cite their sources.
May support PMV for lowering thrombotic markers in mitral stenosis; hypothesis-generating for clinical events, needing RCTs.
Markers of platelet activity (P-selectin), fibrinolysis (d-dimer), thrombin activity (prothrombin fragments 1, 2 [PF1,2] and thrombin-antithrombin III complex [TAT]), and inflammation (interleukin 1β [IL-1β]) were measured in 65 patients with mitral stenosis (MS) before and 2 weeks after percutaneous mitral valvotomy (PMV) and in 23 controls. All markers were significantly higher than the control and significantly decreased after PMV. P-selectin change correlated with the changes in left atrial diameter (LAD), pulmonary artery systolic pressure (PASP), and IL-1β. d-Dimer change had similar correlations, LAD, PASP, and IL-1β. The PF1,2 change correlated with the change in IL-1β. The TAT change correlated with the changes in LAD. The IL-1β change correlated with the changes in PASP. In conclusion, MS is associated with heightened inflammatory, platelet, thrombin, and fibrinolytic activities that decrease after PMV. Altered hemodynamics and reduced inflammatory activity might have a possible role in these changes.
No takes yet. Share an insight, caveat, or question.
Hasan‐Ali et al. (2014) conducted an observational in Mitral stenosis (n=88). Percutaneous mitral valvotomy vs. Baseline (pre-procedure) and healthy controls was evaluated on Markers of platelet activity, fibrinolysis, thrombin activity, and inflammation. Percutaneous mitral valvotomy decreased heightened markers of platelet, thrombin, fibrinolytic, and inflammatory activities in 65 patients with mitral stenosis at 2 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: